
    
      Patients who fulfill eligibility criteria will be entered into the trial.The participant will
      be given a study drug-dosing calendar for each treatment cycle. Each treatment cycle lasts 28
      days (4 weeks), during which time the participant will be taking the study drug orally (by
      mouth) once daily. The diary will also include special instructions for taking the study
      drug. In addition to the administration of the study drugs the participant will be asked to
      return to the clinic at various time points so that additional exams can be performed. These
      study visits may last as long as 2 hours.
    
  